Literature DB >> 1472054

Structure of serum transferrin in carbohydrate-deficient glycoprotein syndrome.

Y Wada1, A Nishikawa, N Okamoto, K Inui, H Tsukamoto, S Okada, N Taniguchi.   

Abstract

The structure of the defective transferrin in carbohydrate-deficient glycoprotein syndrome was characterized. Structurally abnormal sugar chains were not found in reversed phase chromatograms of pyridylaminated derivatives from the transferrin of two patients in different families. Electrospray ionization mass spectrometry of the whole transferrin molecules revealed an abnormal species that was smaller than normal tetrasialotransferrin by 2,200 daltons, just the size of the disialylated biantennary sugar chain. These data indicated that the disialotransferrin specifically found in this syndrome is missing either of two N-linked sugar chains, suggesting a metabolic error in the early steps of protein glycosylation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1472054     DOI: 10.1016/0006-291x(92)92278-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  34 in total

1.  Analysis of serum protein precipitated with antiserum by matrix-assisted laser desorption ionization/time-of-flight and electrospray ionization mass spectrometry as a clinical laboratory test.

Authors:  T Nakanishi; A Shimizu; N Okamoto; A Ingendoh; M Kanai
Journal:  J Am Soc Mass Spectrom       Date:  1995-09       Impact factor: 3.109

2.  Use of combined mass spectrometry methods for the characterization of a new variant of human hemoglobin: The double mutant hemoglobin villeparisis β77(EF1) His → Tyr, β 80 (EF4) Asn → Ser.

Authors:  D Promé; C Deon; J C Promé; H Wajcman; F Galacteros; Y Blouquit
Journal:  J Am Soc Mass Spectrom       Date:  1996-02       Impact factor: 3.109

3.  The identification of abnormal glycoforms of serum transferrin in carbohydrate deficient glycoprotein syndrome type I by capillary zone electrophoresis.

Authors:  O Iourin; T S Mattu; N Mian; G Keir; B Winchester; R A Dwek; P M Rudd
Journal:  Glycoconj J       Date:  1996-12       Impact factor: 2.916

4.  Carbohydrate deficient glycoprotein (CDG) syndrome type I.

Authors:  J Jaeken; G Matthijs; R Barone; H Carchon
Journal:  J Med Genet       Date:  1997-01       Impact factor: 6.318

5.  Dolichol phosphate mannose synthase (DPM1) mutations define congenital disorder of glycosylation Ie (CDG-Ie)

Authors:  S Kim; V Westphal; G Srikrishna; D P Mehta; S Peterson; J Filiano; P S Karnes; M C Patterson; H H Freeze
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

6.  Genotypes and phenotypes of patients in the UK with carbohydrate-deficient glycoprotein syndrome type 1.

Authors:  F Imtiaz; V Worthington; M Champion; C Beesley; J Charlwood; P Clayton; G Keir; N Mian; B Winchester
Journal:  J Inherit Metab Dis       Date:  2000-03       Impact factor: 4.982

7.  Determination of glycan structures and molecular masses of the glycovariants of serum transferrin from a patient with carbohydrate deficient syndrome type II.

Authors:  B Coddeville; H Carchon; J Jaeken; G Briand; G Spik
Journal:  Glycoconj J       Date:  1998-03       Impact factor: 2.916

8.  Carbohydrate-deficient glycoprotein syndrome: not an N-linked oligosaccharide processing defect, but an abnormality in lipid-linked oligosaccharide biosynthesis?

Authors:  L D Powell; K Paneerselvam; R Vij; S Diaz; A Manzi; N Buist; H Freeze; A Varki
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

9.  Secondary disorders of glycosylation in inborn errors of fructose metabolism.

Authors:  E Quintana; L Sturiale; R Montero; F Andrade; C Fernandez; M L Couce; R Barone; L Aldamiz-Echevarria; A Ribes; R Artuch; P Briones
Journal:  J Inherit Metab Dis       Date:  2009-09-20       Impact factor: 4.982

10.  Komrower Lecture. Congenital disorders of glycosylation (CDG): it's all in it!

Authors:  J Jaeken
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.